Search Results - J. Eron

Refine Results
  1. 1

    Spatial epidemiology of recently acquired HIV infections across rural and urban areas of North Carolina. by Margaret Carrel, Joseph J Eron, Michael Emch, Christopher B Hurt

    Published in PLoS ONE (2014-01-01)
    Get full text
    Article


  2. 2

    Risk factors for delayed antiretroviral therapy initiation among HIV-seropositive patients. by Terra V Fatukasi, Stephen R Cole, Richard D Moore, William C Mathews, Jessie K Edwards, Joseph J Eron, CNICS investigators

    Published in PLoS ONE (2017-01-01)
    Get full text
    Article


  3. 3

    CD8 T cells from HIV positive individuals on ART have a skewed differentiation phenotype and impaired proliferative responses by G. Clutton, N. Goonetilleke, O. Council, Y. Xu, J. Warren, D. Lee, M.A. Fernandez, N. Archin, J. Kuruc, J. Eron, C. Gay, D. Margolis

    Published in Journal of Virus Eradication (2017-12-01)
    Get full text
    Article


  4. 4

    HIV-1 Transmission linkages among persons with incident infection to inform public health surveillance by Ann M. Dennis, Simon D.W. Frost, Kimberly Enders, Andrew E. Cressman, Erik Volz, Nicole Adams, William C. Miller, Myron S. Cohen, Victoria Mobley, Erika Samoff, Joseph J. Eron

    Published in EClinicalMedicine (2021-07-01)
    Get full text
    Article


  5. 5

    Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1: subgroup analyses of the phase 3 EMERALD study by Gregory D. Huhn, Joseph J. Eron, Pierre-Marie Girard, Chloe Orkin, Jean-Michel Molina, Edwin DeJesus, Romana Petrovic, Donghan Luo, Erika Van Landuyt, Erkki Lathouwers, Richard E. Nettles, Kimberley Brown, Eric Y. Wong

    Published in AIDS Research and Therapy (2019-08-01)
    Get full text
    Article


  6. 6

    Prioritizing long-acting injectable antiretroviral therapy among key populations: Perceptions of persons living with HIV who inject drugs, ART clinic staff, and policymakers in Vie... by Minh X. Nguyen, Vivian F. Go, Adams L. Sibley, Hanna E. Huffstetler, Trang N.T. Do, Ha V. Tran, Le M. Giang, Teerada Sripaipan, William C. Miller, Joseph J. Eron, Cynthia L. Gay, Sarah E. Rutstein

    Published in PLoS ONE (2025-01-01)
    Get full text
    Article


  7. 7

    Prioritizing long-acting injectable antiretroviral therapy among key populations: Perceptions of persons living with HIV who inject drugs, ART clinic staff, and policymakers in Vie... by Minh X Nguyen, Vivian F Go, Adams L Sibley, Hanna E Huffstetler, Trang N T Do, Ha V Tran, Le M Giang, Teerada Sripaipan, William C Miller, Joseph J Eron, Cynthia L Gay, Sarah E Rutstein

    Published in PLoS ONE (2025-01-01)
    Get full text
    Article


  8. 8

    Cancer risk in HIV patients with incomplete viral suppression after initiation of antiretroviral therapy. by Jennifer S Lee, Stephen R Cole, Chad J Achenbach, Dirk P Dittmer, David B Richardson, William C Miller, Christopher Mathews, Keri N Althoff, Richard D Moore, Joseph J Eron, Center for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS)

    Published in PLoS ONE (2018-01-01)
    Get full text
    Article


  9. 9

    Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1 by Judith A. Aberg, Bronagh Shepherd, Marcia Wang, Jose V. Madruga, Fernando Mendo Urbina, Christine Katlama, Shannon Schrader, Joseph J. Eron, Princy N. Kumar, Eduardo Sprinz, Margaret Gartland, Shiven Chabria, Andrew Clark, Amy Pierce, Max Lataillade, Allan R. Tenorio

    Published in Infectious Diseases and Therapy (2023-09-01)
    Get full text
    Article


  10. 10

    The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatment. by Tina S Skinner-Adams, Alice S Butterworth, Kimberly A Porter, Ronald D'Amico, Fred Sawe, Doug Shaffer, Abraham Siika, Mina C Hosseinipour, Elizabeth Stringer, Judith S Currier, Tsungai Chipato, Robert Salata, Shahin Lockman, Joseph J Eron, Steven R Meshnick, James S McCarthy

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


  11. 11

    Ongoing HIV Transmission and the HIV Care Continuum in North Carolina. by Anna B Cope, Kimberly A Powers, JoAnn D Kuruc, Peter A Leone, Jeffrey A Anderson, Li-Hua Ping, Laura P Kincer, Ronald Swanstrom, Victoria L Mobley, Evelyn Foust, Cynthia L Gay, Joseph J Eron, Myron S Cohen, William C Miller

    Published in PLoS ONE (2015-01-01)
    Get full text
    Article


  12. 12

    Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation. by Rajesh T Gandhi, Deborah K McMahon, Ronald J Bosch, Christina M Lalama, Joshua C Cyktor, Bernard J Macatangay, Charles R Rinaldo, Sharon A Riddler, Evelyn Hogg, Catherine Godfrey, Ann C Collier, Joseph J Eron, John W Mellors, ACTG A5321 Team

    Published in PLoS Pathogens (2017-04-01)
    Get full text
    Article


  13. 13

    Correction: The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial. by Rajesh T. Gandhi, Lu Zheng, Ronald J. Bosch, Ellen S. Chan, David M. Margolis, Sarah Read, Beatrice Kallungal, Sarah Palmer, Kathy Medvik, Michael M. Lederman, Nadia Alatrakchi, Jeffrey M. Jacobson, Ann Wiegand, Mary Kearney, John M. Coffin, John W. Mellors, Joseph J. Eron

    Published in PLoS Medicine (2011-08-01)
    Get full text
    Article


  14. 14

    Antiretroviral drug class and anaemia risk in the current treatment era among people living with HIV in the USA: a clinical cohort study by Richard D Moore, Kenneth Mayer, Greer Burkholder, Susan R Heckbert, Barbara N Harding, Bridget M Whitney, Robin M Nance, Heidi M Crane, W Christopher Mathews, Joseph J Eron, Peter W Hunt, Paul Volberding, Michael S Saag, Mari M Kitahata, Joseph A C Delaney

    Published in BMJ Open (2020-03-01)
    Get full text
    Article


  15. 15

    Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody. by Tin Phan, Carolin Zitzmann, Kara W Chew, Davey M Smith, Eric S Daar, David A Wohl, Joseph J Eron, Judith S Currier, Michael D Hughes, Manish C Choudhary, Rinki Deo, Jonathan Z Li, Ruy M Ribeiro, Ruian Ke, Alan S Perelson, ACTIV-2/A5401 Study Team

    Published in PLoS Pathogens (2024-04-01)
    Get full text
    Article


  16. 16

    Anemia risk factors among people living with HIV across the United States in the current treatment era: a clinical cohort study by B. N. Harding, B. M. Whitney, R. M. Nance, S. A. Ruderman, H. M. Crane, G. Burkholder, R. D. Moore, W. C. Mathews, J. J. Eron, P. W. Hunt, P. Volberding, B. Rodriguez, K. H. Mayer, M. S. Saag, M. M. Kitahata, S. R. Heckbert, J. A. C. Delaney

    Published in BMC Infectious Diseases (2020-03-01)
    Get full text
    Article


  17. 17

    Associations between female birth sex and risk of chronic kidney disease development among people with HIV in the USA: A longitudinal, multicentre, cohort study by Brittany A. Shelton, Deirdre Sawinski, Paul A. MacLennan, Wonjun Lee, Christina Wyatt, Girish Nadkarni, Huma Fatima, Shikha Mehta, Heidi M. Crane, Paige Porrett, Bruce Julian, Richard D. Moore, Katerina Christopoulos, Jeffrey M. Jacobson, Elmi Muller, Joseph J. Eron, Michael Saag, Inga Peter, Jayme E. Locke

    Published in EClinicalMedicine (2022-11-01)
    Get full text
    Article


  18. 18

    Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies by Rachel A. Bender Ignacio, Kara W. Chew, Carlee Moser, Judith S. Currier, Joseph J. Eron, Arzhang Cyrus Javan, Mark J. Giganti, Justin Ritz, Michael Gibbs, Hervé Tchouakam Kouekam, Mark T. Esser, Eric S. Daar, Manish Choudhary, Rinki Deo, Courtney V. Fletcher, Jonathan Z. Li, Michael D. Hughes, Davey Smith, David Alain Wohl

    Published in iScience (2025-03-01)
    Get full text
    Article


  19. 19

    Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy. by Cynthia Gay, Oliver Dibben, Jeffrey A Anderson, Andrea Stacey, Ashley J Mayo, Philip J Norris, JoAnn D Kuruc, Jesus F Salazar-Gonzalez, Hui Li, Brandon F Keele, Charles Hicks, David Margolis, Guido Ferrari, Barton Haynes, Ronald Swanstrom, George M Shaw, Beatrice H Hahn, Joseph J Eron, Persephone Borrow, Myron S Cohen

    Published in PLoS ONE (2011-05-01)
    Get full text
    Article


  20. 20

    Life‐years lost associated with mental disorders in people with HIV: a cohort study in South Africa, Canada and the United States by Yann Ruffieux, John A. Joska, Raynell Lang, Chunyan Zheng, Naomi Folb, Gregory D. Kirk, Angela M. Parcesepe, Michael J. Silverberg, Sonia Napravnik, Kelly Gebo, Joseph J. Eron Jr, Brenna C. Hogan, Keri N. Althoff, Mpho Tlali, David J. Grelotti, Mona Loutfy, Peter F. Rebeiro, Mary‐Ann Davies, Matthias Egger, Gary Maartens, Andreas D. Haas

    Published in Journal of the International AIDS Society (2025-08-01)
    Get full text
    Article


Search Tools: